“This First-in-Human Study shows DurAVRTM THV restored normal, pre-disease blood flow”
Good-bye SAVR!
This will be huge when it gets to market and will be bigger then $10B by 2028 because it will eliminate the need for open heart surgery.
Ann: DurAVR First in Human Study 12 Month Results, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$6.12 |
Change
0.000(0.00%) |
Mkt cap ! $94.85M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2160 | $6.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.08 | 500 | 2 |
View Market Depth
| Last trade - 10.00am 26/06/2025 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable